IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 385 
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed6989    
    Printed259    
    Emailed18    
    PDF Downloaded694    
    Comments [Add]    
    Cited by others 2    

Recommend this journal

 

 EDUCATIONAL FORUM
Year : 2006  |  Volume : 38  |  Issue : 4  |  Page : 231-237

Glucagon like peptide-1: A new therapeutic target for diabetes mellitus


1 Shri Sarvajanik Pharmacy College, Near Arvind Baug, Mehsana-384001, Gujarat, India
2 L.M. College of Pharmacy, Navrangpura, Ahmedabad-380009, Gujarat, India

Correspondence Address:
S K Patel
Shri Sarvajanik Pharmacy College, Near Arvind Baug, Mehsana-384001, Gujarat
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0253-7613.27018

Rights and Permissions

Glucagon-like peptide-1 (GLP-1) is an endogenous peptide secreted from the gut in response to the presence of food. GLP-1 and its longer acting analog exendin-4 have multiple synergistic effects on glucose dependent, insulin secretion pathways of the pancreatic β-cell and on plasticity in neuronal cells. Recently the development of these peptides as a novel therapeutic strategy for non-insulin-dependent (type 2) diabetes mellitus and associated neuropathy has been the focus of much interest. Here we describe the biological actions of GLP-1 and its related analogs.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow